Please ensure Javascript is enabled for purposes of website accessibility
Home / Opinion Digests / No Medicare Drug Coverage for ‘Off Label’ Use (access required)

No Medicare Drug Coverage for ‘Off Label’ Use (access required)

An Alexandria U.S. District Court upholds denial of Medicare Part D coverage for myco­phenolate mofetil, brand name CellCept, for off-label treatment of systemic sclerosis with interstitial lung disease and pulmonary fibrosis; although an ALJ found the drug should be covered based on evidence of nine separate studies showing successful use of the drug for this ...

Leave a Reply